ADVENTA | ADVENTA BERHAD

0.565 (0.0%)
0

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score
ADVENTA | ADVENTA BERHAD

Support & Resistance

ATR Trailing Stop: 0.55

Support
Last Price
Resistance
Price 0.54 0.545 0.55 0.56 0.565 0.565 0.565 0.575 0.59 0.595 0.6
Volume (M) 6.4 4.4 5.7 9.2 12.7 12.7 9.3 6.2 14.5 9.0

Gann Support: 0.53/0.49 | Resistance: 0.57/0.61

*Highlighted column shows significant volume at the support or resistance area.

Technical Trend

Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Pivot Point

S2
S1
P
R1
R2
Daily 0.54 0.555 0.57 0.585 0.6
Weekly 0.54 0.555 0.57 0.585 0.6

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
18 May 23 Q1 Mar 23 1 31 Dec 23 13.75 -0.83 -0.82 -6.0% 0.00 -0.54 63.8% 24.8% 78.6% 217.9%
24 Feb 23 Q4 Dec 22 4 31 Dec 22 8.39 -3.52 -3.85 -45.9% 0.00 -2.52 18.2% 62.9% 101.0% 204.6%
29 Nov 22 Q3 Sep 22 3 31 Dec 22 10.26 -2.35 -1.92 -18.7% 0.00 -1.25 53.1% 76.4% 2435.4% 175.7%
29 Aug 22 Q2 Jun 22 2 31 Dec 22 21.90 0.27 0.08 0.4% 0.00 0.05 19.7% 9.2% 88.3% 98.9%
27 May 22 Q1 Mar 22 1 31 Dec 22 18.30 0.91 0.70 3.8% 0.00 0.46 19.1% 41.2% 81.0% 154.2%
23 Feb 22 Q4 Dec 21 4 31 Dec 21 22.61 2.38 3.68 16.3% 0.00 2.41 47.9% 78.0% 45.5% 139.6%
24 Nov 21 Q3 Sep 21 3 31 Dec 21 43.42 3.51 2.53 5.8% 0.00 1.66 116.4% 200.2% 67.2% 148.4%
25 Aug 21 Q2 Jun 21 2 31 Dec 21 20.06 7.73 7.71 38.4% 0.00 5.05 54.9% 56.7% 697.3% 356.0%
28 May 21 Q1 Mar 21 1 31 Dec 21 12.96 -1.29 -1.29 -10.0% 0.00 -0.73 2.0% 5.2% 86.1% 228.1%
26 Feb 21 Q4 Dec 20 4 31 Dec 20 12.71 -9.98 -9.29 -73.1% 0.00 -6.08 12.2% 9.1% 77.6% 43.8%
25 Nov 20 Q3 Sep 20 3 31 Dec 20 14.47 -5.23 -5.23 -36.1% 0.00 -3.38 68.8% 51.9% 409.1% 117.3%
26 Aug 20 Q2 Jun 20 2 31 Dec 20 46.37 1.58 1.69 3.6% 0.00 1.11 239.1% 401.4% 67.8% 540.4%
21 May 20 Q1 Mar 20 1 31 Dec 20 13.67 0.91 1.01 7.4% 0.00 0.66 17.4% 61.1% 115.6% 182.0%
27 Feb 20 Q4 Dec 19 4 31 Dec 19 11.64 -6.06 -6.46 -55.5% 7.00 -4.23 22.3% 49.8% 121.4% 76.5%
26 Nov 19 Q3 Sep 19 3 31 Dec 19 9.52 29.43 30.21 317.3% 0.00 19.77 3.0% 0.7% 7967.4% 5409.5%
29 Aug 19 Q2 Jun 19 2 31 Dec 19 9.25 0.36 -0.38 -4.2% 0.00 -0.25 9.0% 31.1% 68.8% 150.7%
30 May 19 Q1 Mar 19 1 31 Dec 19 8.49 -0.43 -1.23 -14.5% 0.00 -0.80 9.2% 44.8% 95.5% 275.1%
28 Feb 19 31 Dec 18 Other 31 Dec 18 7.77 -27.06 -27.43 -352.9% 0.00 -17.95 18.9% 44.0% 4720.2% 4169.3%
26 Dec 18 31 Oct 18 Other 31 Dec 18 9.59 -0.61 -0.57 -5.9% 0.00 -0.37 28.6% 21.1% 175.2% 146.3%
28 Sep 18 Q3 Jul 18 3 31 Oct 18 13.42 1.37 0.76 5.6% 0.00 0.50 12.6% 27.6% 7.8% 2126.5%
20 Jun 18 Q2 Apr 18 2 31 Oct 18 15.36 1.32 0.70 4.6% 0.00 0.46 10.6% 26.1% 4.2% 384.1%
28 Mar 18 Q1 Jan 18 1 31 Oct 18 13.89 1.49 0.67 4.8% 0.00 0.44 14.3% 48.0% 391.8% 252.9%
29 Dec 17 Q4 Oct 17 4 31 Oct 17 12.15 0.35 -0.23 -1.9% 0.00 -0.15 15.5% 15.0% 779.4% 263.8%
19 Sep 17 Q3 Jul 17 3 31 Oct 17 10.52 0.46 0.03 0.3% 0.00 0.02 13.6% 37.0% 76.5% 107.5%
22 Jun 17 Q2 Apr 17 2 31 Oct 17 12.18 0.68 0.14 1.2% 0.00 0.09 29.8% 29.8% 24.1% 208.5%
28 Mar 17 Q1 Jan 17 1 31 Oct 17 9.38 0.04 0.19 2.0% 0.00 0.13 11.2% 23.8% 35.5% 79.6%
27 Dec 16 Q4 Oct 16 4 31 Oct 16 10.57 0.80 0.14 1.3% 0.00 0.09 37.7% 5.2% 131.0% 81.3%
29 Sep 16 Q3 Jul 16 3 31 Oct 16 7.68 -0.10 -0.46 -5.9% 0.00 -0.30 18.2% 18.6% 1068.1% 155.7%
28 Jun 16 Q2 Apr 16 2 31 Oct 16 9.38 0.35 0.05 0.5% 0.00 0.03 23.7% 16.5% 95.0% 93.7%
29 Mar 16 Q1 Jan 16 1 31 Oct 16 12.30 1.36 0.94 7.6% 0.00 0.61 22.4% 10.2% 24.1% 21.2%
18 Dec 15 Q4 Oct 15 4 31 Oct 15 10.05 1.13 0.76 7.5% 0.00 0.49 6.5% 14.1% 7.5% 35.2%
22 Sep 15 Q3 Jul 15 3 31 Oct 15 9.44 1.23 0.82 8.7% 0.00 0.53 16.0% 6.5% 10.1% 40.0%
23 Jun 15 Q2 Apr 15 2 31 Oct 15 11.24 1.21 0.74 6.6% 0.00 0.49 0.7% 90.4% 4.1% 86.0%
17 Mar 15 31/01/15 1 31/10/15 11.16 1.44 0.77 6.9% 0.00 0.51 4.6% 57.1% 33.7% 44.8%

Historical Dividends

Financial Ratios

EPS -4.26 sen
Trailing PE (Sector Median: 31.5) 0.0
PEG 0.0
Altman Z 1.2
Beaver -0.73
Current Ratio 3.96
Debt-Equity (DE) Ratio 0.27
FCF Yield -14.23 %
Revenue QoQ 63.82 %
Revenue YoY -24.84%
Profit QoQ 78.57 %
Profit YoY -217.86 %
Profit Margin (Sector Median: 0.3) -11.98 %
ROE (ROIC: -10.33) -10.33 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 31.5)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 0.3)
ROE (ROIC: -10.3)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.41
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] -0.82
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


MISS KWEK SIEW LENG added 154000.0 units announced on 27 Sep 2022 at ~RM0.5

MISS KWEK SIEW LENG added 181000.0 units announced on 22 Sep 2022 at ~RM0.5

MISS KWEK SIEW LENG added 50000.0 units announced on 13 Sep 2022 at ~RM0.515

KWEK SIEW LENG added 115000.0 units announced on 09 Sep 2022 at ~RM0.5

MISS KWEK SIEW LENG reduced 650000.0 units announced on 30 Apr 2021 at ~RM1.96

MR TOH SENG THONG reduced 140000.0 units announced on 30 Apr 2021 at ~RM1.96

DATO DR NORRAESAH BINTI HAJI MOHAMAD reduced 140000.0 units announced on 30 Apr 2021 at ~RM1.96

MR EDMOND CHEAH SWEE LENG reduced 140000.0 units announced on 28 Aug 2020 at ~RM2.67

MR TOH SENG THONG reduced 20000.0 units announced on 19 Aug 2020 at ~RM3.0

MISS KWEK SIEW LENG reduced 150000.0 units announced on 06 Aug 2020 at ~RM4.7

Summary


Market Cap: 86 M.

Number of Shares: 152 M.

Adjusted Float: 47.6%.

Stock highly correlated with

CAREPLS (98%)

HLT (97%)

COMFORT (93%)

SOLUTN (93%)

Adventa Bhd is dedicated to the business of medical services and related supplies manufacturing. Since the disposal of its glove manufacturing businesses, the company has strategically focused on medical services to hospitals, institutions, clinical centers and patients directly. The rapidly growing demand for better healthcare has put an enormous burden on governments to increase healthcare spending and at the same time improve quality of care without exponentially increasing costs. Adventa has the experience to manage this demand of better care at affordable cost by working in transparent partnership with healthcare centers to drive down cost lost through scale inefficiency.

Sectors: Healthcare, Coronavirus, Health Care Equipment & Services

Code: 7191

Website: http://www.adventa.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 14-Apr-2022

Shareholder Value (M)
Low Chin Guan 33.36
Clearstream Banking S.A 11.91
Low Lea Kwan 3.12
K Mayah A/P Kuppusamy @ Naghuran 0.41
UBS AG 0.36
Michael Heng Chun Hong 0.34
Koh Eng Poh 0.28
Lee Kok Hin 0.26
Theng Yoke Weng 0.25
Yap Yok Long 0.25
Tan Pow Choo @ Wong Seng Eng 0.22
Premier Elite Marketing Sdn. Bhd. 0.2
Liew Guan Tuck 0.17
Ker Aa Tin 0.17
Liew Thau Sen 0.16
Lau Kien Wee 0.16
Chang Jong Yu 0.15
Barclays Capital Securities Ltd. 0.15
Wong Kok Sin 0.14
Lee Bee Sin 0.14
Wong Yeen Ni 0.14
Ng Yan Peng 0.13
Lim Soon Huat 0.13
Syed Ahmad Khalid Bin Syed Mohammed 0.12
Choi Kim Joo 0.12
M.Baaden Bin Asasmulia 0.12
Saw Hai Earn 0.11
Yap Leng Hong 0.11
Koh Boon Poh 0.11

This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.